Glaxo and Genmab drop IV version of MS immune drug
Glaxo and Genmab drop IV version of MS immune drug
GlaxoSmithKline PLC and Genmab A/S will end the development of an intravenous form of a drug intended to treat autoimmune diseases like lupus and multiple sclerosis, and focus on an injectable version.
The companies said an injectable version of Arzerra (ofatumumab) should be more convenient for patients and have fewer side effects. The drug can also be used to treat rheumatoid arthritis...Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1397
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 1 Replies
- 1845 Views
-
Last post by goellerc
-
- 0 Replies
- 1138 Views
-
Last post by ElliotB
-
- 61 Replies
- 13782 Views
-
Last post by jimmylegs
-
- 3 Replies
- 5007 Views
-
Last post by NHE
-
- 5 Replies
- 14123 Views
-
Last post by gibbledygook
-
- 1 Replies
- 1562 Views
-
Last post by ElliotB
-
- 0 Replies
- 1041 Views
-
Last post by DIM
-
- 0 Replies
- 489 Views
-
Last post by NHE
-
- 0 Replies
- 1667 Views
-
Last post by NHE